Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240628 · ClinicalTrials.gov registry record · Phase 4
Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 76
- Enrollment target
NCT02240628 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 76 participants.
The verdict
NCT02240628, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 76 participants
- Enrollment target
Study Summary
The main objective is to evaluate if combining placing the Synera patch and using Propofol /Lidocaine mixture will further decrease the pain associated with the IV injection of Propofol.
Interventions
- DRUG Saline
- DRUG Lidocaine
- DEVICE Lidocaine/tetracaine transdermal patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02240628
The ClinicalTrials.gov registry entry for NCT02240628 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline is the first listed.
NCT02240628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02240628 about?
NCT02240628 is a clinical study titled "Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection". The main objective is to evaluate if combining placing the Synera patch and using Propofol /Lidocaine mixture will further decrease the pain associated with the IV injection of Propofol.
What is the current status of trial NCT02240628?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2014-08. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02240628?
The interventions under investigation include: Saline (DRUG), Lidocaine (DRUG), Lidocaine/tetracaine transdermal patch (DEVICE).
Who is sponsoring clinical trial NCT02240628?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.